Anders Hamsten

Q: What Schools Are Affiliated With Anders Hamsten

Anders Hamsten is affiliated with the following schools: Uppsala University, University of Oxford, University College London, University of British Columbia, Lund University, Karolinska Institute, University of Southampton

Anders Hamsten's AcademicInfluence.com Rankings

Anders Hamsten

Philosophy

#4081

World Rank

#6464

Historical Rank

Logic

#1621

World Rank

#2422

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Anders Hamsten Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anders Hamsten's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetic studies of body mass index yield new insights for obesity biology (2015) (3549)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) (2511)
Discovery and Refinement of Loci Associated with Lipid Levels (2013) (2475)
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (2010) (2087)
Hundreds of variants clustered in genomic loci and biological pathways affect human height (2010) (1961)
Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk (2011) (1928)
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes (2012) (1839)
Defining the role of common variation in the genomic and biological architecture of adult human height (2014) (1805)
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION (1987) (1626)
A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease (2015) (1567)
Large-scale association analysis identifies new risk loci for coronary artery disease (2012) (1507)
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. (1985) (1437)
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. (2009) (1242)
New genetic loci link adipose and insulin biology to body fat distribution (2014) (1227)
Genome-wide association study identifies eight loci associated with blood pressure (2009) (1225)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) (1170)
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study (2002) (1125)
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility (2014) (933)
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution (2010) (897)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis (2012) (864)
Common variants associated with plasma triglycerides and risk for coronary artery disease (2013) (767)
Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. (1995) (765)
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways (2012) (758)
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance (2012) (756)
Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index (2015) (666)
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits (2018) (659)
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. (2005) (647)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies (2012) (646)
The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. (1993) (639)
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease (2011) (638)
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. (1999) (628)
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. (2009) (614)
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man (1992) (582)
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture (2013) (568)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) (559)
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans (2017) (547)
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data (2014) (547)
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity (2005) (544)
The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2015) (532)
Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression* (1996) (531)
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. (2008) (527)
Postprandial lipoproteins and progression of coronary atherosclerosis. (1994) (521)
Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution (2009) (516)
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients (1996) (506)
Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid (1989) (444)
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk (2017) (428)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction (2014) (426)
Multi-ethnic genome-wide association study for atrial fibrillation (2018) (425)
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure (2011) (424)
FTO genotype is associated with phenotypic variability of body mass index (2012) (407)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTS (1986) (382)
Gene expression in human NAFLD. (2008) (368)
Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits (2013) (365)
Psoriasis is associated with lipid abnormalities at the onset of skin disease. (2006) (361)
Genetic fine-mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci (2015) (349)
Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. (1991) (349)
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals (2016) (347)
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction (2005) (346)
Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis (2009) (345)
Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus (2001) (344)
Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium (2010) (344)
Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. (1990) (325)
Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects (2007) (319)
Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. (1990) (315)
LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis (2001) (315)
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. (1990) (315)
A Common Functional Polymorphism (C→A Substitution at Position −863) in the Promoter Region of the Tumour Necrosis Factor-α (TNF-α) Gene Associated With Reduced Circulating Levels of TNF-α (1999) (309)
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. (1996) (308)
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis (2017) (308)
Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity (2007) (305)
Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. (2002) (305)
Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women (2001) (301)
The impact of low-frequency and rare variants on lipid levels (2015) (300)
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans (2009) (297)
Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease: The Diabetes Atherosclerosis Intervention Study (DAIS) (2003) (291)
Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility (2005) (286)
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. (2012) (282)
Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. (1999) (276)
TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content (2014) (258)
Proneness to Formation of Tight and Rigid Fibrin Gel Structures in Men with Myocardial Infarction at a Young Age (1996) (258)
High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. (1991) (258)
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. (1993) (250)
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. (2001) (249)
Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. (1998) (248)
Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation (2017) (243)
Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals (1998) (238)
Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease (2011) (228)
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. (2018) (221)
Genetically determined height and coronary artery disease. (2015) (220)
Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. (2004) (216)
Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study. (2012) (209)
GENETIC AND CULTURAL INHERITANCE OF PLASMA FIBRINOGEN CONCENTRATION (1987) (209)
Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. (1998) (207)
Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. (1998) (203)
Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. (1996) (200)
Haemostatic function in myocardial infarction. (1986) (199)
Genetic evidence of assortative mating in humans (2017) (199)
Genome-Wide Association Identifies Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes (2011) (197)
Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. (2000) (196)
Very Low-Density Lipoprotein Activates Nuclear Factor-κB in Endothelial Cells (1999) (194)
Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. (1994) (192)
miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development (2014) (192)
Insight into the nature of the CRP-coronary event association using Mendelian randomization. (2006) (191)
Fibrin Gel Network Characteristics and Coronary Heart Disease: Relations to Plasma Fibrinogen Concentration, Acute Phase Protein, Serum Lipoproteins and Coronary Atherosclerosis (1992) (190)
Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. (1986) (189)
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study (2011) (185)
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility (2015) (185)
Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance (2008) (180)
Plasma Procarboxypeptidase U in Men with Symptomatic Coronary Artery Disease (2000) (180)
The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. (1990) (179)
Gene × Physical Activity Interactions in Obesity: Combined Analysis of 111,421 Individuals of European Ancestry (2013) (178)
Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. (1993) (178)
Blood pressure loci identified with a gene-centric array. (2011) (177)
Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. (1992) (176)
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. (2004) (175)
Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe (2002) (175)
Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. (1992) (174)
Relationship between CAD Risk Genotype in the Chromosome 9p21 Locus and Gene Expression. Identification of Eight New ANRIL Splice Variants (2009) (174)
Allele-Specific Regulation of Matrix Metalloproteinase-7 Promoter Activity Is Associated With Coronary Artery Luminal Dimensions Among Hypercholesterolemic Patients (2001) (172)
Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. (1995) (170)
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). (1998) (166)
Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. (1990) (166)
Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1 (1999) (165)
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. (2004) (165)
Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. (2001) (164)
A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. (1999) (162)
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals (2020) (161)
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. (2013) (160)
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. (2012) (158)
Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance (2012) (157)
Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. (1999) (156)
Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease (2017) (153)
Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. (1991) (152)
The Trans-Ancestral Genomic Architecture of Glycemic Traits (2020) (151)
Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. (2013) (149)
Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits (2017) (149)
Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction (2014) (147)
The Role of β-Fibrinogen Genotype in Determining Plasma Fibrinogen Levels in Young Survivors of Myocardial Infarction and Healthy Controls from Sweden (1993) (145)
Directional dominance on stature and cognition in diverse human populations (2015) (144)
Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. (2003) (144)
Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. (1992) (143)
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. (2005) (143)
Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. (2008) (142)
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors (2016) (141)
A common variant in the gene for lipoprotein lipase (Asp9→Asn) : functional implications and prevalence in normal and hyperlipidemic subjects (1995) (141)
Activation of coagulation factor VII during alimentary lipemia. (1994) (137)
Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. (1993) (137)
Association of Genetic Risk Variants With Expression of Proximal Genes Identifies Novel Susceptibility Genes for Cardiovascular Disease (2010) (136)
Evidence That Peroxisome Proliferator–Activated Receptor Delta Influences Cholesterol Metabolism in Men (2003) (136)
Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. (1999) (136)
Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. (2007) (135)
TNF-α: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease (2003) (135)
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. (2010) (134)
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. (2011) (133)
Multiethnic Meta-Analysis of Genome-Wide Association Studies in >100 000 Subjects Identifies 23 Fibrinogen-Associated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease (2013) (133)
Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction (2005) (132)
Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. (2002) (127)
Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy (2003) (125)
Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction (2013) (122)
Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. (2004) (122)
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia (2007) (121)
Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. (1992) (121)
Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney (2017) (121)
ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. (2008) (121)
Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. (1995) (120)
Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II and B. (1986) (120)
Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies (2016) (118)
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. (1997) (116)
Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women’s Genome Health Study (2009) (115)
Multi-Organ Expression Profiling Uncovers a Gene Module in Coronary Artery Disease Involving Transendothelial Migration of Leukocytes and LIM Domain Binding 2: The Stockholm Atherosclerosis Gene Expression (STAGE) Study (2009) (115)
Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms (2006) (115)
The hemostatic system and coronary heart disease. (1993) (114)
Relation of Plasma Levels and Composition of Apolipoprotein B‐Containing Lipoproteins to Angiographically Defined Coronary Artery Disease in Young Patients With Myocardial Infarction (1993) (114)
Genome wide association study identifies KCNMA1 contributing to human obesity (2011) (114)
Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. (1998) (113)
A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. (1998) (109)
LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. (1999) (108)
Human Evidence That the Apolipoprotein A-II Gene Is Implicated in Visceral Fat Accumulation and Metabolism of Triglyceride-Rich Lipoproteins (2001) (108)
Human Evidence That the Cystatin C Gene Is Implicated in Focal Progression of Coronary Artery Disease (2004) (106)
HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. (1993) (106)
Insulin, intact and split proinsulin, and coronary artery disease in young men. (1995) (105)
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution (2011) (104)
Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. (1999) (104)
Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals. (1992) (104)
A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. (2007) (103)
Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome 17 (2006) (102)
Treatment with combined oral contraceptives induces a rise in serum C‐reactive protein in the absence of a general inflammatory response (2006) (102)
Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population‐based controls (2004) (101)
Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients. (1988) (100)
Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome (2005) (99)
Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke: Replicated Findings in Two Nested Case–Control Studies Based on Independent Cohorts (2005) (99)
Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. (1995) (99)
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. (2008) (98)
Regional Variation in Plasminogen Activator Inhibitor-1 Expression in Adipose Tissue from Obese Individuals (2000) (98)
GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes (2018) (98)
Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. (1994) (97)
Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]). (1997) (96)
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome (2007) (96)
Progression of Carotid Intima-Media Thickness as Predictor of Vascular Events: Results from the IMPROVE Study (2013) (96)
Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors (2007) (96)
In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. (1996) (95)
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. (2000) (94)
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. (2012) (93)
Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. (2016) (92)
Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells. (1998) (91)
Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. (1995) (91)
Peripheral Sensory Neuropathy Associates With Micro- or Macroangiopathy (2008) (89)
Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. (2006) (89)
Hemostatic function and coronary artery disease. (1995) (89)
Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men (2003) (88)
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. (2007) (88)
Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. (1997) (88)
Eight blood pressure loci identified by genome-wide association study of 34,433 people of European ancestry (2009) (88)
Unraveling Divergent Gene Expression Profiles in Bicuspid and Tricuspid Aortic Valve Patients with Thoracic Aortic Dilatation: The ASAP Study (2011) (86)
Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes. (2007) (86)
Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function (2005) (86)
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance (2004) (84)
Circulating PCSK9 Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors (2016) (84)
Haemostatic, Endothelial and Lipoprotein Parameters and Blood Pressure Levels in Women with a History of Preeclampsia (1999) (83)
Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction (2005) (82)
Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. (2004) (82)
Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease (2015) (81)
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. (2013) (80)
Secretory Phospholipase A2-IIA and Cardiovascular Disease (2013) (78)
Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy (2007) (78)
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease (2017) (78)
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. (1998) (77)
Regulation of Plasma PAI-1 Concentrations in HAART-Associated Lipodystrophy During Rosiglitazone Therapy (2003) (77)
Transcriptional Profiling Uncovers a Network of Cholesterol-Responsive Atherosclerosis Target Genes (2008) (77)
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. (2009) (76)
Risk factors for coronary artery disease in families of young men with myocardial infarction. (1987) (76)
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway. (2001) (76)
Impaired fibrinolysis and risk of thromboembolism. (1991) (76)
Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma. (1998) (76)
Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function. (1991) (76)
Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps (2016) (75)
PPARδ activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells (2003) (75)
The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. (2011) (75)
A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. (2016) (75)
Genome-wide analysis yields new loci associating with aortic valve stenosis (2017) (74)
The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients (1996) (74)
Alterations of VLDL composition during alimentary lipemia. (1997) (74)
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals (2001) (73)
Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation. (1998) (72)
Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation (2015) (72)
Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. (2006) (71)
Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease. (2000) (71)
Association of Plasminogen Activator Inhibitor (PAI)-1 (SERPINE1) SNPs With Myocardial Infarction, Plasma PAI-1, and Metabolic Parameters: The HIFMECH Study (2007) (70)
Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. (2003) (70)
Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men (1993) (69)
TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. (2003) (69)
Difference in Matrix-Degrading Protease Expression and Activity Between Thrombus-Free and Thrombus-Covered Wall of Abdominal Aortic Aneurysm (2005) (68)
Associations of autozygosity with a broad range of human phenotypes (2019) (68)
Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1). (2003) (67)
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. (2003) (67)
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study (2005) (67)
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. (2005) (66)
Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease. (2006) (66)
IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. (2009) (66)
Socioeconomic status and determinants of hemostatic function in healthy women. (1999) (65)
The plasminogen activator inhibitor‐1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study (2003) (65)
Common and Low-Frequency Genetic Variants in the PCSK9 Locus Influence Circulating PCSK9 Levels (2012) (64)
Involvement of SIK3 in Glucose and Lipid Homeostasis in Mice (2012) (64)
Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies. (2006) (64)
Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. (1996) (63)
Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm (2010) (62)
Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. (2000) (62)
Elevated Levels of Factor VII Activity in the Postprandial State: Effect of the Factor VII Arg-GIn Polymorphism (1994) (61)
A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE (2010) (61)
The Q/E27 polymorphism in the β2‐adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride‐rich lipoproteins (2000) (61)
Insulin regulation of MCP-1 in human adipose tissue of obese and lean women. (2008) (61)
In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing’s syndrome is associated with increased regeneration of cortisol by 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue (2004) (60)
Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. (2008) (59)
Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII. (2002) (59)
A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape (2016) (59)
Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome. (2004) (59)
Impaired Splicing of Fibronectin Is Associated With Thoracic Aortic Aneurysm Formation in Patients With Bicuspid Aortic Valve (2011) (59)
Psychosocial work conditions before myocardial infarction in young men. (1987) (59)
Oxidised‐HDL3 induces the expression of PAI‐1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization (2004) (59)
Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability (2020) (58)
Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM (2016) (58)
Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. (1999) (58)
Genome-wide genetic homogeneity between sexes and populations for human height and body mass index. (2015) (58)
Obesity‐Related Derangements of Coagulation and Fibrinolysis: A Study of Obesity‐Discordant Monozygotic Twin Pairs (2012) (58)
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects (2005) (58)
Associations of genotypes at the apolipoprotein AI‐CIII‐AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses (1994) (57)
Fibrinolysis and atherosclerosis: An update (1994) (57)
Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. (2004) (57)
The effects of the strain of returning to work on the risk of cardiac death after a first myocardial infarction before the age of 45. (1991) (56)
Sex hormone--binding globulin--a surrogate marker for the prothrombotic effects of combined oral contraceptives. (2004) (56)
Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. (2002) (56)
Association of genetic variation on chromosome 9p21.3 and arterial stiffness (2009) (56)
Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men. (2003) (56)
Haemostatic Factors and Inhibitors and Coronary Artery Bypass Grafting: Preoperative Alterations and Relations to Graft Occlusion (1994) (54)
Plasma Cholesterol–Induced Lesion Networks Activated before Regression of Early, Mature, and Advanced Atherosclerosis (2014) (54)
A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia. (2000) (54)
Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction (2005) (54)
Native fibrin gel networks and factors influencing their formation in health and disease. (1990) (53)
Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms (2004) (53)
Carotid plaque-thickness and common carotid IMT show additive value in cardiovascular risk prediction and reclassification (2017) (53)
Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR‐PSOX gene (2005) (52)
Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism (2008) (51)
Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. (2015) (51)
Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes (2015) (51)
Increased expression of the macrophage markers and of 11β-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity (2007) (51)
Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). (1996) (51)
Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation. (2008) (50)
Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells. (1999) (50)
Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors (2015) (49)
Identification of the BCAR1-CFDP1-TMEM170A Locus as a Determinant of Carotid Intima-Media Thickness and Coronary Artery Disease Risk (2012) (49)
Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. (1999) (49)
Autoantibodies against modified low-density lipoproteins in coronary artery disease. (2003) (49)
Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men (2000) (49)
GeneiASE: Detection of condition-dependent and static allele-specific expression from RNA-seq data without haplotype information (2016) (48)
Plasma lipoproteins enhance tissue factor-independent factor VII activation. (2000) (48)
Genetic variants of TNFSF4 and risk for carotid artery disease and stroke (2009) (48)
Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. (2004) (48)
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. (2001) (48)
Low density lipoprotein-induced growth of U937 cells: a novel method to determine the receptor binding of low density lipoprotein. (1990) (47)
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. (2007) (46)
Platelet Activity In Vivo in Hyperlipoproteinemia – Importance of Combined Hyperlipidemia (1998) (46)
Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk (2011) (46)
Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease (2014) (45)
Human genetic evidence that OX40 is implicated in myocardial infarction. (2006) (45)
Relationship of Tissue Factor Pathway Inhibitor Activity to Plasma Lipoproteins and Myocardial Infarction at a Young Age (1994) (44)
Apolipoprotein B-48. (1996) (44)
Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. (1986) (44)
Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3' end of the human gene. (1992) (44)
Association of TERC and OBFC1 Haplotypes with Mean Leukocyte Telomere Length and Risk for Coronary Heart Disease (2013) (43)
The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. (2005) (43)
Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors (2010) (43)
Serine protease inhibitor A3 in atherosclerosis and aneurysm disease. (2012) (43)
Allele-specific MMP-3 transcription under in vivo conditions. (2006) (43)
Fatty acid handling protein expression in adipose tissue, fatty acid composition of adipose tissue and serum, and markers of insulin resistance (2006) (43)
PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. (2003) (42)
Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. (2000) (42)
Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.M400195-JLR200 (2004) (41)
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction (2006) (41)
Effects of fibrate compounds on expression of plasminogen activator inhibitor-1 by cultured endothelial cells. (1999) (40)
Plasma CD93 concentration is a potential novel biomarker for coronary artery disease (2011) (40)
Causal Relevance of Blood Lipid Fractions in the Development of Carotid Atherosclerosis: Mendelian Randomization Analysis (2013) (40)
Plasma IL-5 concentration and subclinical carotid atherosclerosis (2015) (40)
A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution. (2003) (39)
Coagulation Factor V (Arg506 → Gln) Mutation and Early Saphenous Vein Graft Occlusion after Coronary Artery Bypass Grafting (1998) (39)
Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. (2006) (39)
Serum 25-Hydroxyvitamin D Concentration in Subclinical Carotid Atherosclerosis (2013) (39)
Genome‐wide association study with additional genetic and post‐transcriptional analyses reveals novel regulators of plasma factor XI levels (2017) (39)
Comparison of plasminogen activator inhibitor activity and antigen in plasma samples. (1987) (39)
Correlation of serum IGF‐I and IGFBP‐1 and ‐3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle‐aged men (2008) (39)
Correction: Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution (2009) (39)
Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2 (2014) (39)
Gemfibrozil Reduces Thrombin Generation in Patients with Combined Hyperlipidaemia, without Influencing Plasma Fibrinogen, Fibrin Gel Structure or Coagulation Factor VII (1996) (38)
Common Genetic Determinants of Lung Function, Subclinical Atherosclerosis and Risk of Coronary Artery Disease (2014) (37)
Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2016) (37)
Differential expression of peroxisomal proliferator activated receptors α and δ in skeletal muscle in response to changes in diet and exercise (2006) (37)
Cardiomyopathy, pericarditis and myocarditis in a population‐based cohort of inpatients with coeliac disease (2007) (36)
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor. (1999) (36)
Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients. (2009) (36)
Genetic evidence that the putative receptor binding domain of apolipoprotein B (residues 3130 to 3630) is not the only region of the protein involved in interaction with the low density lipoprotein receptor. (1991) (35)
Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. (2009) (35)
Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals (2002) (35)
Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. (2011) (35)
A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein. (1999) (34)
Genetic Diversity in the Matrix Metalloproteinase Family: Effects on Function and Disease Progression a (2000) (34)
The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age. (1991) (34)
Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure. (2000) (34)
Increased Arterial Blood Pressure and Vascular Remodeling in Mice Lacking Salt-Inducible Kinase 1 (SIK1) (2015) (34)
5 Fibrinolysis and atherosclerosis (1995) (34)
A Genome-Wide Association Study Identifies KNG1 as a Genetic Determinant of Plasma Factor XI Level and Activated Partial Thromboplastin Time (2012) (34)
9 Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease (1990) (33)
Correlations between fibrinolytic function and acute myocardial infarction. (1990) (33)
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. (2016) (32)
Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease (2002) (32)
Genetic variation in CADM2 as a link between psychological traits and obesity (2019) (32)
GWAS-identified loci for coronary heart disease are associated with intima-media thickness and plaque presence at the carotid artery bulb. (2015) (31)
Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels (2009) (31)
High-density lipoprotein subfraction 3 decreases ADAMTS-1 expression induced by lipopolysaccharide and tumor necrosis factor-α in human endothelial cells (2004) (31)
Salt-inducible kinase 1 influences Na+,K+-ATPase activity in vascular smooth muscle cells and associates with variations in blood pressure (2011) (31)
Postprandial Enrichment of Remnant Lipoproteins With ApoC-I in Healthy Normolipidemic Men With Early Asymptomatic Atherosclerosis (2002) (31)
Lower serum concentration of matrix metalloproteinase‐3 in the acute stage of myocardial infarction (2006) (31)
Integrative studies implicate matrix metalloproteinase‐12 as a culprit gene for large‐artery atherosclerotic stroke (2017) (31)
Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids. (2010) (31)
Relationships of Insulin and Intact and Split Proinsulin to Haemostatic Function in Young Men with and without Coronary Artery Disease (1995) (30)
Stored iron levels and myocardial infarction at young age. (1994) (30)
Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes (2018) (29)
Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis. (2014) (29)
Increased platelet-derived mitogenic activity in plasma of young patients with coronary atherosclerosis. (1986) (29)
Detection of Circulating hcmv-miR-UL112-3p in Patients with Glioblastoma, Rheumatoid Arthritis, Diabetes Mellitus and Healthy Controls (2014) (29)
Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration (2006) (28)
Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years. (2012) (28)
PCSK6 Is a Key Protease in the Control of Smooth Muscle Cell Function in Vascular Remodeling (2020) (28)
Genetic association and gene expression analysis identify FGFR1 as a new susceptibility gene for human obesity. (2011) (28)
Postprandial Plasma ApoB-48 Levels Are Influenced by a Polymorphism in the Promoter of the Microsomal Triglyceride Transfer Protein Gene (2002) (27)
Relationships of thrombosis and fibrinolysis to atherosclerosis (1994) (27)
Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study. (1995) (27)
Association of a sequence variant in DAB2IP with coronary heart disease (2011) (27)
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL‐6 concentration (2007) (27)
Dyslipoproteinemic changes in borderline hypertension. (1994) (27)
Genotype–phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion (2005) (27)
Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia. (2002) (26)
Tumour necrosis factor-α (TNF-α) polymorphisms –857C/A and –863C/A are associated with TNF-α secretion from human adipose tissue (2001) (26)
Glucose tolerance and insulin response to glucose in nondiabetic young male survivors of myocardial infarction. (1987) (26)
The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence (2014) (26)
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes (2018) (26)
Apolipoproteins, dyslipoproteinaemia and premature coronary heart disease. (2009) (26)
A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima–media thickness) (2014) (26)
No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction (2003) (26)
Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk (1998) (26)
Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (26)
The feasibility of velocity vector imaging by transesophageal echocardiography for assessment of elastic properties of the descending aorta in aortic valve disease. (2010) (25)
Exome sequencing followed by genotyping suggests SYPL2 as a susceptibility gene for morbid obesity (2014) (25)
Statins in rheumatoid arthritis—two birds with one stone? (2004) (25)
Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men. (2014) (25)
No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis (2016) (25)
Genetic factors determining thrombosis and fibrinolysis. (1992) (24)
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. (2005) (24)
Comparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study (2017) (24)
Combined Chromatin and Expression Analysis Reveals Specific Regulatory Mechanisms within Cytokine Genes in the Macrophage Early Immune Response (2012) (24)
Prognostic value of plasma C‐reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis (2003) (24)
Association between circulating immune complexes, complement C4 null alleles, and myocardial infarction before age 45 years. (1995) (24)
Rapid activation of haemostasis after hormonal emergency contraception (2006) (24)
ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes (2008) (23)
Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism. (2008) (23)
Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles. (2006) (23)
A Common Polymorphism in the Promoter Region of the TNFSF4 Gene Is Associated with Lower Allele-Specific Expression and Risk of Myocardial Infarction (2011) (23)
A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology. (2019) (23)
In Vivo Stimulation of Vascular Plasminogen Activator Inhibitor-1 Production by very Low-Density Lipoprotein Involves Transcription Factor Binding to a VLDL-Responsive Element (2000) (22)
Effects of HDL3 on the expression of matrix-degrading proteases in human endothelial cells. (2003) (22)
70 – Atherosclerosis, Thrombosis, and Vascular Biology (2012) (22)
Very-low-density lipoprotein activates nuclear factor kappa B in endothelial cells (1998) (22)
Alternative splicing of human peroxisome proliferator-activated receptor delta (PPARdelta):effects on translation efficiency and trans-activation ability (2007) (22)
Plasma cytokines and risk of coronary heart disease in the PROCARDIS study (2018) (22)
Allele-specific chromatin remodeling of the tumor necrosis factor-α promoter (2006) (21)
Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise. (2006) (21)
Allele-specific regulation of MTTP expression influences the risk of ischemic heart disease[S] (2010) (21)
A postulated phylogenetic tree for the human apolipoprotein B gene: unpredicted haplotypes are associated with elevated apo B levels. (1993) (21)
Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes. (2008) (20)
Effects of Genetic Loci Associated with Central Obesity on Adipocyte Lipolysis (2016) (20)
Analysis of the Role of Interleukin 6 Receptor Haplotypes in the Regulation of Circulating Levels of Inflammatory Biomarkers and Risk of Coronary Heart Disease (2015) (20)
Retardation of Coronary Atherosclerosis: The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and Other Angiographic Trials (1997) (20)
High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease. (1996) (20)
Functional Analysis of a Carotid Intima-Media Thickness Locus Implicates BCAR1 and Suggests a Causal Variant (2015) (20)
Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (Nature Genetics (2010) 42 (105-116)) (2010) (20)
Human intestinal alkaline phosphatase—release to the blood is linked to lipid absorption, but removal from the blood is not linked to lipoprotein clearance (1993) (19)
Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease. (1994) (19)
Normalisation of the composition of very low density lipoprotein in hypertriglyceridemia by nicotinic acid. (1990) (19)
Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project (2016) (19)
Fibrinolytic Proteins and Progression of Coronary Artery Disease in Relation to Gemfibrozil Therapy (2000) (19)
Association between high levels of growth factors in plasma and progression of coronary atherosclerosis (1992) (19)
Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism. (2014) (18)
Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study (2007) (18)
Variants at the Endocannabinoid Receptor CB1 Gene (CNR1) and Insulin Sensitivity, Type 2 Diabetes, and Coronary Heart Disease (2011) (18)
Coagulation factors and hyperlipidaemia (1991) (18)
Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP 5 and STX 2 (2014) (17)
Polymorphisms in the thrombopoietin gene are associated with risk of myocardial infarction at a young age. (2001) (17)
Genetics of Atherothrombosis and Thrombophilia (2010) (17)
Design features of a five-year Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). (1995) (17)
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort (2014) (17)
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of β-fibrinogen genotype and environmental factors (2004) (17)
Analysis with the exome array identifies multiple new independent variants in lipid loci. (2016) (17)
Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction (2010) (17)
Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middleaged women with and without manifest coronary heart disease (2005) (17)
Lim Domain Binding 2: A Key Driver of Transendothelial Migration of Leukocytes and Atherosclerosis (2014) (17)
Toll-Like Receptor 3 Influences Glucose Homeostasis and β-Cell Insulin Secretion (2015) (17)
Publisher Correction: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits (2018) (17)
Secretory Phospholipase A2-IIA and Cardiovascular Disease A Mendelian Randomization Study (2017) (16)
Genome-wide association study of circulating interleukin 6 levels identifies novel loci (2021) (16)
Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease. (2012) (16)
Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype. (1995) (16)
Allele-specific chromatin remodeling of the tumor necrosis factor-alpha promoter. (2006) (16)
NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction. (2012) (16)
Long-term prognostic significance of M mode echocardiography in young men after myocardial infarction. (1995) (15)
Molecular genetics as the route to understanding, prevention, and treatment (1996) (15)
Lack of Salt-Inducible Kinase 2 (SIK2) Prevents the Development of Cardiac Hypertrophy in Response to Chronic High-Salt Intake (2014) (15)
Genomic evaluation of circulating proteins for drug target characterisation and precision medicine (2020) (15)
Coagulation Factor VII in Middle-aged Women with and without Coronary Heart Disease (2001) (15)
Phospholipid antibodies in cardiovascular disease. (2009) (14)
Type A behaviour, education and psychosocial work characteristics in relation to ischemic heart disease--a case control study of young survivors of myocardial infarction. (1986) (14)
Correlation between plasma levels of growth factors and von Willebrand factor. (1989) (14)
Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed‐forward loop between LXR and autophagy (2019) (14)
Genetic loci on chromosome 5 are associated with circulating levels of interleukin-5 and eosinophil count in a European population with high risk for cardiovascular disease (2016) (14)
Genetic analysis of over one million people identifies 535 novel loci for blood pressure (2017) (14)
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men. (2007) (14)
ACQUIRED OBESITY INCREASES CD68 AND TNF-α AND DECREASES ADIPONECTIN GENE EXPRESSION IN ADIPOSE TISSUE. A study in monozygotic twins. (2006) (13)
DGAT1 Participates in the Effect of HNF4A on Hepatic Secretion of Triglyceride-Rich Lipoproteins (2010) (13)
Very Low-Density Lipoprotein Activates Nuclear Factor- (cid:107) B in Endothelial Cells (1999) (13)
The plasma protein profile and cardiovascular risk differ between intima-media thickness of the common carotid artery and the bulb: A meta-analysis and a longitudinal evaluation. (2020) (12)
Increased Levels of Circulating Fatty Acids Are Associated with Protective Effects against Future Cardiovascular Events in Nondiabetics. (2017) (12)
Impaired glucose and insulin metabolism in borderline hypertension. (1994) (12)
Genetic determinants of plasma β2‐glycoprotein I levels: a genome‐wide association study in extended pedigrees from Spain (2013) (12)
DNA polymorphism studies. Approaches to elucidating multifactorial ischaemic heart disease: the apo B gene as an example. (1992) (11)
Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study (2020) (11)
High-density lipoprotein subfraction 3 decreases ADAMTS-1 expression induced by lipopolysaccharide and tumor necrosis factor-alpha in human endothelial cells. (2004) (11)
Identification of a Functional Apolipoprotein E Promoter Polymorphism Regulating Plasma Apolipoprotein E Concentration (2013) (11)
Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction (2008) (11)
Autoantibodies against basement membrane collagen type IV are associated with myocardial infarction (2014) (11)
Association Between Uric Acid, Carotid Intima‐Media Thickness, and Cardiovascular Events: Prospective Results From the IMPROVE Study (2021) (11)
LDL oxidative modification and carotid atherosclerosis: results of a multicenter study. (2012) (11)
Shortened megakaryocyte-platelet regeneration time in young survivors of myocardial infarction. (1985) (11)
Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease. (1990) (10)
Transcriptomic profiling of experimental arterial injury reveals new mechanisms and temporal dynamics in vascular healing response (2020) (10)
Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro. (1998) (10)
Influence of ABO Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes (2019) (10)
Hormonal regulation of circulating C-reactive protein in men. (2005) (10)
von Willebrand Factor in Plasma and Urine of Men with Premature Coronary Artery Disease (1992) (10)
High Density Lipoproteins and Coronary Atherosclerosis (2005) (10)
Discovering Genetic Interactions in Large-Scale Association Studies by Stage-wise Likelihood Ratio Tests (2015) (9)
C4 null alleles and myocardial infarction. (1999) (9)
Coronary Angiography and Pathogenesis of Coronary Artery Disease in Young Male Survivors of Myocardial Infarction (1986) (9)
No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 Subjects (2014) (9)
Comparative study of echo- and angiocardiographically determined regional left ventricular wall motion in recent myocardial infarction. (1984) (9)
Identification of genetic variation that determines levels of plasma triglycerides and hypercoagulability (1994) (9)
Is the adiposity‐associated FTO gene variant related to all‐cause mortality independent of adiposity? Meta‐analysis of data from 169,551 Caucasian adults (2015) (9)
Lipids as a coronary risk factor: analysis of hyperlipidaemias. (1993) (9)
F11 is associated with recurrent VTE in women (2016) (9)
Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction (2013) (9)
Human Genetic Evidence for Involvement of CD137 in Atherosclerosis (2014) (9)
APC resistance during the normal menstrual cycle (2007) (9)
Soluble CD93 Is Involved in Metabolic Dysregulation but Does Not Influence Carotid Intima-Media Thickness (2016) (8)
A gene-centric study of common carotid artery remodelling (2013) (8)
Quest for genes and mechanisms linking the human chromosome 9p21.3 locus to cardiovascular disease. (2012) (8)
Postprandial lipaemia and coronary heart disease (1998) (8)
Erratum to: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits : (Nature Genetics, (2018), 50, 10, (1412-1425), 10.1038/s41588-018-0205-x) (2018) (8)
Erratum: miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development (2015) (7)
Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes (2021) (7)
A priori-defined Mediterranean-like dietary pattern predicts cardiovascular events better in north Europe than in Mediterranean countries☆ (2019) (7)
Duffy antigen receptor genetic variant and the association with Interleukin 8 levels. (2015) (7)
Thrombospondins and premature coronary artery disease: time to go beyond genotype-phenotype association studies. (2003) (7)
Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk. (1998) (7)
Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation (2005) (7)
Diastolic and Systolic Function as Predictors of Exercise Capacity after Myocardial Infarction in Young Men (1998) (7)
Fibrin gel architecture influences endogenous fibrinolysis and may promote coronary artery disease. (2006) (7)
Non-insulin-dependent diabetes mellitus and atherosclerosis: a lipoprotein perspective. (1994) (6)
In vitro and in vivo lipolysis of plasma triglycerides increases the resistance to oxidative modification of low‐density lipoproteins (2003) (6)
Random glucose GWAS in 493,036 individuals provides insights into diabetes pathophysiology, complications and treatment stratification (2021) (6)
Genetic variation at the plasminogen activator inhibitor-1 (PAI-1) locus (1990) (6)
The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals (2020) (6)
Abstract 17123: Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels (2010) (5)
Profiles of histidine-rich glycoprotein associate with age and risk of all-cause mortality (2020) (5)
Free apolipoprotein (a) in abetalipoproteinaemia (1989) (5)
Alcohol consumption in relation to carotid subclinical atherosclerosis and its progression: results from a European longitudinal multicentre study (2020) (5)
VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia (2018) (5)
Abnormalities of composition and of in vitro lipolysis products of human small very low density lipoproteins in hypertriglyceridemia. (1990) (5)
Possibilities of DNA Analysis for the Detection of Predisposition to Thrombotic Disease (1992) (5)
Circulating immune complexes induced by food proteins implicated in precocious myocardial infarction (2001) (5)
Tumour necrosis factor-alpha (TNF-alpha) polymorphisms-857C/A and -863C/A are associated with TNF-alpha secretion from human adipose tissue. (2001) (4)
The way ahead in the management of unstable coronary artery disease. (1997) (4)
Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation (2017) (4)
GENETIC INHERITANCE AND PLASMA FIBRINOGEN (1988) (4)
The susceptibility of low density lipoprotein to chemical oxidation is closely related to proneness to biological modification. (1995) (4)
Common variants in the thrombomodulin gene as a risk for myocardial infarction in the north of Europe (HIFMECH Study) (2004) (4)
Association of lifelong occupation and educational level with subclinical atherosclerosis in different European regions. Results from the IMPROVE study. (2017) (4)
Supplementary Material 7 (2014) (3)
3P-0718 Peroxisome proliferator activated receptor genotypes in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men (2003) (3)
Supplementary Material 5 (2014) (3)
ALLELE SPECIFIC DIFFERENTIAL BINDING OF HEPG2 NUCLEAR EXTRACTS TO A COMMON POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) PROMOTER WHICH IS ASSOCIATED WITH ALTERED PLASMA PAI-1 LEVELS (1991) (3)
Multi-ethnic genome-wide association study for atrial fibrillation (2018) (3)
Soluble CD 93 is involved in metabolic dysregulation but does not influence carotid intima-media thickness (2016) (3)
Remnant-like lipoproteins concentration in plasma is strongly associated with early signs of carotid atherosclerosis in healthy 50-year old men. (1998) (3)
Levels of histidine-rich glycoprotein variants in human blood are associated to chronological age and predict mortality (2019) (3)
ADIPOSE TISSUE INFLAMMATION AND LIVER FAT IN PATIENTS WITH HIGHLY 3 (2008) (3)
Mitogenic activity in connection with coronary angioplasty. (1993) (3)
Quest for genes regulating plasma fibrinogen concentration: still a long way to go. (2005) (3)
Myocardial infarction at a young age: mechanisms and management (1991) (3)
Erratum to: Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps : (Nature Genetics, (2016), 48, 11, (1303-1312), 10.1038/ng.3668) (2018) (3)
Non-insulin-dependent diabetes and atherosclerosis : a lipoprotein perspective (1994) (3)
Supplementary Material 3 (2015) (3)
W12-P-066 Insight into the nature of the CRP-coronary event association using mendelian randomisation (2005) (3)
Bezafibrate following acute myocardial infarction: important findings from the bezafibrate coronary atherosclerosis intervention trial (1997) (3)
Sex hormoneebinding globulindA surrogate marker for the prothrombotic effects of combined oral contraceptives (2004) (3)
Monday, 27 August 2012 (2012) (3)
Supplementary Material 6 (2014) (3)
CAROTID INTIMA MEDIA THICKNESS AS MARKER OF ATHEROSCLEROSIS: RESULTIS OF THE IMPROVE STUDY (2008) (2)
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men. (2008) (2)
Plasma C-Reactive Protein and Lipoprotein Levels, and Progression of Coronary Artery Disease after Myocardial Infarction Treated with Thrombolysis (2005) (2)
Functional studies of an 4G/5G polymorphism in the PAI-1 promoter region which is associated with myocardial infarction at a young age (1994) (2)
Remnants and coronary artery disease progression (1994) (2)
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation (2017) (2)
Common variants in genes encoding plasma lipid-transfer and lipolytic proteins are associated with increased LDL particle size (2002) (2)
Sex hormone-binding globulin--a surrogate marker for the prothrombic effects of combined oral contraceptives. (2006) (2)
WO5-OR-4 ALTERNATIVE SPLICING OF HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA: EFFECTS ON TRANSLATION EFFICIENCY AND TRANS-ACTIVATION ABILITY (2007) (2)
Antibodies to phospholipids in thrombotic disease (1989) (2)
Novel blood pressure locus and gene discovery using GWAS and expression datasets from blood and the kidney (2017) (2)
Fast and general tests of genetic interaction for genome-wide association studies (2017) (2)
C 4 null alleles and myocardial infarction/SUB (1999) (2)
HIGH-DENSITY LIPOPROTEIN SUBFRACTION 3 DECREASES ADAMTS-1 EXPRESSION INDUCED (2004) (2)
HYPERTRIGLYCERIDEMIA, TRIGLYCERIDE-RICH LIPOPROTEINS, AND CORONARY ATHEROSCLEROSIS (1991) (2)
A common polymorphism in the promoter region of TNF-alpha gene determining the serum TNF-alpha concentration (1999) (2)
A vldl response element in the promoter region of the human pai-1 gene implicated in the impaired fibrinolysis of hypertriglyceridaemia (1996) (2)
Gene-environment interaction in determining plasma lipids and dietary response: the effect of common mutations in the gene for lipoprotein lipase (D9N and N291S) (1996) (2)
[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]. (2006) (2)
Intake of food rich in saturated fat in relation to subclinical atherosclerosis and potential modulating effects from single genetic variants (2021) (2)
Gene-gene interaction between apoB and apoE in determining plasma levels and heterogeneity of apoB-containing lipoproteins (1998) (2)
Fatty acid binding proteins in different human adipose tissue depots: Relationships to serum insulin concentrations (2000) (1)
Novel mechanisms regulating Factor XI plasma levels (2016) (1)
Author Correction: Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps (2018) (1)
, Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and (2005) (1)
A common promoter polymorphism affecting transcription of the MTP-gene influences lipoprotein phenotype in familial hypercholesterolaemia (1998) (1)
Effects of atorvastatin on fasting and postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidemia (2000) (1)
74. Genetic control of PAI-1 (1996) (1)
97 Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals (1997) (1)
Erratum: Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height ((The American Journal of Human Genetics (2010) 88 (6-18)) (2012) (1)
Postprandial metabolism and composition of very low density lipoproteins in relation to atherosclerosis (1999) (1)
FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100 - DETECTION AND CLINICAL CHARACTERISTICS (1990) (1)
Gene-gene interaction between apo E and apo B in determining plasma levels of apo B-containing lipoproteins (1998) (1)
Loci for insulin processing and secretion provide insight into type 2 diabetes risk. (2023) (1)
1.P.309 Complement factor C3 genotype and risk of MI (1997) (1)
Cross-Sectional Gene-Smoking Interaction Analysis in Relation to Subclinical Atherosclerosis-Results From the IMPROVE Study. (2023) (1)
REMNANT LIPOPROTEINS AND CORONARY ARTERY DISEASE PROGRESSION (1995) (1)
Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus (2020) (1)
A common functional polymorphism in the promoter region of the MTP gene influences the plasma LDL level (1998) (1)
Genetic Variation in the Human Stromelysin Promoter: Effects on Gene Expression and Progression of Coronary Atherosclerosis (1997) (1)
FGL1 as a modulator of plasma D‐dimer levels: Exome‐wide marker analysis of plasma tPA, PAI‐1, and D‐dimer (2021) (1)
Interaction of the lipoprotein lipase ASN291 -> SER mutation with body mass index in determining elevated plasma lipid concentrations in hyperlipidaemic subjects, myocardial infarction survivors and healthy controls (1995) (1)
Supplementary Material 4 (2015) (1)
Serum 25-hydroxyvitamin D relationships to carotid intima-media thickness (cIMT) and cIMT progression in a European high-risk population (2012) (1)
Supplementary Material 9 (2013) (1)
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (2022) (1)
Publisher Correction: Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability (2021) (1)
Genome-wide analysis yields new loci associating with aortic valve stenosis (2018) (1)
HLA-DRB1*04 is a novel fetal susceptibility allele in congenital heart block (2011) (1)
Abstract 318: Matrix Metalloproteinase 12 is Causally Implicated in Cardiovascular Disease (2016) (1)
Supplementary Material 15 (2013) (1)
Repeated exercise and redistribution thallium-201 scintigrams in patients with myocardial infarction treated with timolol or placebo. (1986) (1)
Very Low-Density Lipoprotein Activates Nuclear Factor-kB in Endothelial Cells (1999) (1)
Profiles of circulating histidine-rich glycoprotein associate with chronological age and risk of all-cause mortality (2018) (1)
Functional studies of a common promoter polymorphism in the microsomal triglyceride transfer protein gene (MTP) (1999) (1)
Discovery and Refinement Supplementary (2015) (1)
Abstract 150: Identification of SYNPO2, SYNM, LMOD1, PDLIM7 and PLN as Novel Markers of Smooth Muscle Cells in Atherosclerosis (2015) (0)
Abstract 564: Influence of Coronary Artery Disease-Associated Genetic Variants on Risk of Venous Thromboembolism (2013) (0)
Tu-P7:72 Atherosclerosis before and after transformation of fatty streaks into plaques — implications for disease expansion and gene expression (2006) (0)
A7.23 The HLA Locus Contains Novel Foetal Susceptibility Alleles for Congenital Heart Block with Significant Paternal Influence (2013) (0)
Mendelian randomisation and disease risk estimates for C-reactive protein (CRP) (2005) (0)
Correction: Combined Chromatin and Expression Analysis Reveals Specific Regulatory Mechanisms within Cytokine Genes in the Macrophage Early Immune Response (2012) (0)
1SOA03-4 DAIS: New results and links between correcting lipid abnormalities and cardiovascular benefits (2003) (0)
Th-P15:2 Influence of INSIG-1 and INSIG-2 silencing on the expression of genes involved in fatty acid and cholesterol metabolism in HUH7 human hepatoma cells (2006) (0)
Diabetes mellitus, insulin resistance and the metabolic syndrome in patients without previously known diabetes (2003) (0)
We-W35:2 Inherited and acquired risk factors for juvenile myocardial infarction in an European cohort (2006) (0)
Meta-analyzed single SNP interactions with physical activity* on BMI. (2013) (0)
Genotype-specific increase in plasma concentrations of activated coagulation factorVII in response to experimental inflammation A link between infection and acute myocardial infarction? (2017) (0)
Title Increased levels of circulating fatty acids are associated with protective effects against future cardiovascular events in non-diabetics (2018) (0)
P4918PCSK6 is a key protease in the control of smooth muscle cell function in vascular remodelling (2017) (0)
The PenTanucleoTide inserTion in hsPa1B Gene is associaTed wiTh idioPaThic inflammaTory myoPaThy (2013) (0)
Abstract 647: Identification of Platelet Derived Growth Factors A, B, C and D Specific Role in Vascular Remodeling (2015) (0)
INFLUENCE OF INTRALUMINAL THROMBUS ON STRUCTURAL FEATURES AND GENE EXPRESSION OF THE ANEURYSM WALL (2004) (0)
Regulation in brown adipose tissue thermogenesis through the receptor Alk 7 (2015) (0)
PO15-403 ENDOTHELIAL ACTIVITY IS RELATED TO DIET AND COMPONENTS OF THE METABOLIC SYNDROME, BUT NOT TO ADVANCED GLYCATION END-PRODUCTS IN HEALTHY SWEDISH MEN (2007) (0)
4.P.196 Postprandial very low density lipoproteins: Composition and cellular interactions (1997) (0)
W56 TELOMERES ARE SHORTER IN PATIENTS WITH POLYGENIC AND MONOGENIC FORMS OF CORONARY HEART DISEASE (2010) (0)
PO6-176 HUMAN EVIDENCE FOR THE INVOLVEMENT OF INSIG-2 IN THE ADIPOSE TISSUE METABOLISM (2007) (0)
Associated Disorders in Celiac Disease Örebro Studies in Medicine 27 Associated Disorders in Celiac Disease (2009) (0)
FRI0127 Atherosclerosis and arterial disease in systemic lupus erythematosus (2001) (0)
Author Correction: Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps (2018) (0)
Acquired Obesity Changes Adipose Tissue MRNA Expression, Increases Abdominal and Liver Fat, and Causes Insulin Resistance in Monozygotic Twins (2004) (0)
Molecular Phenotypes of Coronary Artery Disease : The Stockholm Atherosclerosis Gene Expression (STAGE) Study (2013) (0)
Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function (2022) (0)
Abstract 17360: Genome-Wide Meta-Analysis of Plasminogen Activator Inhibitor Type 1 (PAI-1) Identifies a New Locus Independent of the Serpine1 4G/5G Polymorphism (2010) (0)
Th-P15:56 DGAT1 mediates the effect of the MODY1 gene HNF4A on hepatic secretion of triglyceride-rich lipoproteins (2006) (0)
Genetic determination of haemostatic risk factors (1999) (0)
Abstract 13512: Chemokines and Carotid Intima-Media Thickness in a European Population at High Risk for Cardiovascular Events: Results From the IMPROVE Study (2016) (0)
Haemostatic function in myocardial infarction Patients and methods STUDY (2005) (0)
1P-0054 Characterization of the human homologue to the Ath1 atherosclerosis susceptibility locus in mice (2003) (0)
3.P.391 Circulating immune complexes containing food antigens in premature myocardial infarction (1997) (0)
Abstract State-of-the-eart: 4, 5 & 6Fibrinolysis and atherosclerosis: An update (1994) (0)
Identiﬁcation of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study (2009) (0)
Apo B genetic variants that modulate postprandial lipoprotein metabolism (1996) (0)
[The proposal of the National Board of Health and Welfare counteracts knowledge development within health care]. (2003) (0)
SA98GENETIC ANALYSIS OF CADM2, A POSSIBLE LINK BETWEEN MENTAL AND PHYSICAL HEALTH (2019) (0)
3P-0776 Dietary influence on LDL particle size in subjects with different degrees of insulin resistance (2003) (0)
We-P11:50 The stockholm atherosclerosis gene expression (stage) study - multiorgan expression profiling in well-characterized coronary artery disease patients (2006) (0)
Association of lifelong occupation and educational level with subclinical atherosclerosis is stronger in north Europe, independently of conventional risk factors and dietary habits. Results from the IMPROVE study (2018) (0)
Unsaturated fatty acids increase PAI-1 expression in endothelial cells (1998) (0)
Coronary angiographic changes during 2 years after myocardial infarction largely undetected by repeated tomographic thallium-201 scintigraphy and not reflected by clinical symptoms. (1993) (0)
THROMBOSIS AND HEMOSTASIS Rare and low-frequency variants and their association with plasma levels of ﬁ brinogen, FVII, FVIII, and vWF (2015) (0)
Genetic variation in CADM2 as a link between psychological traits and obesity (2019) (0)
Abstract 14527: MicroRNAs Are Novel Plasma Biomarkers for Diagnosis and Prognosis of Abdominal Aortic Aneurysm Disease (2013) (0)
Ameta-analysis of 120 246 individuals identi fi es 18 new loci for fi brinogen concentration (2016) (0)
W14-IS-001 The fibrinogen gene loci revisited (2005) (0)
Genome-Wide Association Identi ﬁ es Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes (2011) (0)
Abstract 2076: Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease (2009) (0)
Tu-PL2:3 Quest for genes predisposing to atherothrombosis (2006) (0)
November Updates: People &Places (2016) (0)
Mannose-binding lectin genotype and phenotype and their impact on cardiovascular prognosis in patients with type 2 diabetes and myocardial infarction; a report from the DIGAMI 2 trial (2010) (0)
Whole-genome expression profiling of human plaques to identify genes relevant for atherosclerosis : the Stockholm Atherosclerosis Gene Expression Study, Stockholm Söder Hospital, Sweden (SöS-STAGE) (2013) (0)
F11 is associated with recurrent event of VTE in women : a prospective cohort study (2015) (0)
Contents of volumes 263, 264, 266–289 (1998) (0)
Data on the association between a simplified Mediterranean diet score and the incidence of combined, cardio and cerebro vascular events (2019) (0)
1P-0131 Genetic and structural evaluation of fatty acid transport protein-4 (FATP4) in relation to markers of the insulin resistance syndrome (2003) (0)
Lipidomic profile and cardiovascular events in diabetic subjects (2014) (0)
3.P.407 Oxidised LDL induced T cell proliferation; LDL from patients with coronary artery disease inhibited the effect of oxidised LDL (1997) (0)
myocardial infarction . echocardiography in young men after Long-term prognostic significance of M mode (0)
4P-1130 Expression of ADAMTS-1 in apo E null mouse (2003) (0)
Peroxisome Proliferator Activated Receptor delta genotype in relation to cardiovascular risk factors and risk of coronary disease in hypercholesterolemic men (2002) (0)
2.P.344 Platelet function in hypercholesterolemia - importance of combine hyperlipidemia (1997) (0)
P575Regulation of purinergic signaling in response to arterial injury (2018) (0)
Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study (2020) (0)
Abstract 16492: A Study of 63,253 Cases and 126,820 Controls Identifies Multiple Novel Loci for Coronary Artery Disease and Detects Independent Signals in Many of the Established Ones (2011) (0)
Biomarkers for prediction of CVD in type 2 diabetes (2013) (0)
Metabolic predictors of CVD in type 2 diabetes (2013) (0)
Functional polymorphism in matrix metalloproteinase-9 gene associated with coronary atherosclerosis (2000) (0)
PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY (2007) (0)
Does diffuse coronary atherosclerosis affect the relation between coronary stenoses and uptake of thallium-201 after exercise? (1992) (0)
of genetically altered mice Use of echocardiography for the phenotypic assessment (2015) (0)
Edinburgh Research Explorer Secretory Phospholipase A2-IIA and Cardiovascular Disease (2018) (0)
Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease (2009) (0)
[New methods accelerate the development of thrombolytic agents]. (1991) (0)
Supporting information S 1 Text for Modeling genetic interactions using generalized linear models (2016) (0)
Inhibition of aortic atherosclerosis in apolipoprotein E-deficient mice by recombinant apolipoprotein A-I Milano (1998) (0)
Artery Disease With Coronary Artery Luminal Dimensions in Diabetic Patients With Manifest Coronary Allele-Specific Regulation of Matrix Metalloproteinase-12 Gene Activity Is Associated (2000) (0)
Sex hormone-binding globulin e A surrogate marker for the prothrombic effects of combined oral contraceptives (2006) (0)
Plasminogen activator inhibitor in plasma and myocardial infarction at young age (1988) (0)
Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes (2019) (0)
Insight into the nature of the URF-uukunary event association using mendelian randomisation (2005) (0)
Levels of histidine-rich glycoprotein in human blood predict accelerated aging (2018) (0)
Abstract 129: Investigation of Atherosclerosis in Association with Arthritic Inflammation (2013) (0)
Gene-environment interactions determining the risk of thrombosis (1994) (0)
Dissection of genes in the type I interferon pathway reveals two novel risk loci for SLE (2012) (0)
Stimulation of F-Cell Production in Patients with Sickle-Cell Anemia Treated with Cytarabine or Hydroxyurea 1571 (1985) (0)
3P-0717 Effects of diet and exercise on the regulation of PPARα, δ and γ expression in rat skeletal muscle and visceral adipose tissue (2003) (0)
The Measurement of Cardiac Reactivity in Clinical Populations (1985) (0)
Poster session IV * Friday 10 December 2010, 14:00-18:00 (2010) (0)
Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Print (1998) (0)
Tu-P7:213 Relationships between autoantibodies against modified LDL and advanced glycation end-products in clinically healthy men (2006) (0)
Abstract 20011: Novel Genetic Variants Associated With Circulating Soluble Glycoprotein 130 Levels in The IMPROVE Study (2017) (0)
16. Gene-environment interaction in the determination of plasma fibrinogen levels (1996) (0)
Impaired fibrinolytic function in coronary heart disease (1990) (0)
Induction of PAI-1 expression by native and ultra violet-oxidized low density lipoprotein (1995) (0)
Allele-specifi c regulation of MTTP expression infl uences the risk of ischemic heart disease (2010) (0)
A C -> A polymorphism at position 6390 within intron 6 of the thrombopoietin gene is associated with myocardial infarction in young Swedish men (1998) (0)
Genetic regulation of the MMP-7 and MMP-12 gene expression (2000) (0)
Remnants of postprandial triglyceride-rich lipoproteins and atherosclerosis (1999) (0)
Insulin, lipoproteins and hemostatic function (1994) (0)
Interadventitia Common Carotid Artery Diameter Improves Carotid IMT Ability to Predict Coronary Events: Data from the IMPROVE Study: Carotid Intima Media Thickness (IMT) and IMT Progression as Predictors of Vascular Events in a High-Risk European Population (2010) (0)
Abstract 267: CD93: A Novel Myocardial Infarction- Associated Protein with Glucose Regulatory Properties in Humans and Mice (2015) (0)
Long-term prognostic value of thallium scintigraphy and coronary angiography after myocardial infarction in young men (1992) (0)
4P-1132 Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease (2003) (0)
COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE (2010) (0)
W14-P-006 Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction (2005) (0)
Periodontitis, Atherosclerotic Cardiovascular Disease and Vitamin D (2009) (0)
Very low density lipoprotein and free fatty acids stimulate nuclear factor-κB activation in endothelial cells (1999) (0)
Interaction between genotype and environmental factors in the development of atherosclerotic-thrombotic disease (1994) (0)
The ANRIL locus on chromosome 9p21 affects stiffness of the abdominal aorta (2008) (0)
WO2-OR-6 STEAROYL COA DESATURASE (SCD) ACTIVITY IN HUMAN ADIPOSE TISSUE IS INCREASED IN THE METABOLIC SYNDROME (2007) (0)
Poster session I * Thursday 9 December 2010, 08:30-12:30 (2010) (0)
The endogenous fibrinolytic enzyme system: Regulation and significance for cardiovascular disease (2000) (0)
GENE ENVIRONMENT INTERACTIONS AND THE RISK OF THROMBOSIS (1995) (0)
4.C.6 Postprandial lipaemia and coronary heart disease (1997) (0)
INTERACTION BETWEEN GENOTYPE AND ENVIRONMENTAL-FACTORS IN THE DEVELOPMENT OF ATHEROSCLEROTIC-THROMBOTIC ARTERIAL DISEASES (1991) (0)
Verema - an affinity proteomics study to identify and translate plasma biomarkers for venous thromboembolism (2015) (0)
Healthy 50-Year-Old Men LDL Particle Size Distribution Is Associated With Carotid Intima-Media Thickness in (1999) (0)
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits (2018) (0)
Publisher Correction: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits (2018) (0)
Fibrinolysis and atherosclerosis. (1995) (0)
Abstract 18975: Increased Arterial Blood Pressure and Vascular Fibrosis/remodeling in Mice Lacking Salt-inducible Kinase 1 (sik1) (2013) (0)
Reduced serum paraoxonase activity is associated with progression of atherosclerosis and new clinical events: Bezafibrate coronary atherosclerosis intervention trial (1996) (0)
ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP (2009) (0)
Alterations of VLDL composition during alimentary (1997) (0)
The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals (2021) (0)
altered levels of plasma plasminogen activator inhibitor-1 activity Genetic variation at the plasminogen activator inhibitor-1 locus is associated with (2011) (0)
Abstract 721: Vascular Assessment - New Application for Velocity Vector Imaging (2009) (0)
We-W35:6 Matrix metalloproteinase-1 gene haplotype influences risk of myocardial infarction (2006) (0)
Abstract 23: Identification of NCF4 as a Novel Regulator in Arterial Remodeling and Advanced Atherosclerosis (2017) (0)
Does CRP Play a Causal Role in the Development of Coronary Heart Disease: Results of a Mendelian Randomisation Experiment Involving 128,935 People (2009) (0)
Contributors (2012) (0)
Abstract 17979: A Genome-Wide Association Study of Risk of Coronary Artery Disease in European and South Asian Populations (2010) (0)
Abstract 14779: Array-Based Profiling Reveals Biomarker and Therapeutic Potential for Different MicroRNAs in Patients With Symptomatic Carotid Stenosis (2013) (0)
Discovering gene-environment interactions with Lasso (2019) (0)
Plasma cholesterol–induced regression of early, mature, and advanced atherosclerosis (2014) (0)
Detection of condition-dependent and static allele-specific expression from RNA-seq data (2016) (0)
Diffuse coronary atheromatosis and sensitivity/specificity to detect coronary stenosis by exercise thallium-201 scintigraphy (1988) (0)
Genetic determinants of vascular diameter and the risk of abdominal aortic aneurysm (2012) (0)
Diabetes: A Growing CHD Epidemic (2002) (0)
Abstract 636: Accelerated Atherosclerosis in the Context of Rheumatoid Arthritis (2016) (0)
Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus Clinical Investigation and Reports (2001) (0)
P3645Interleukin 8 (IL-8), but not GRO-a, associates with carotid intima-media thickness. Results from the IMPROVE study (2018) (0)
P623A simplified score for adherence to a Mediterranean dietary pattern predicts carotid atherosclerosis progression (2018) (0)
The role of a common variant in the CETP gene on size distribution of LDL subfractions (2000) (0)
MOLECULAR GENETIC-ANALYSIS OF THE APOLIPOPROTEIN-B ANTIGEN GROUP (X/Y) POLYMORPHISM (1991) (0)
A COMMON POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) PROMOTER SHOWS ALLELE SPECIFIC DIFFERENTIAL BINDING TO HEPG2 NUCLEAR EXTRACTS AND IS ASSOCIATED WITH ALTERED PLASMA PAI-1 LEVELS (1991) (0)
Mo-P6:449 A new OX40L promoter haplotype showing association with coronary artery disease in the procardis trio family and scarf cohorts (2006) (0)
Identification of novel genetic risk loci determine fetal outcome in congenital heart block (2012) (0)
Independent relevance of renal function for coronary artery disease (2010) (0)
MS338 ECHOCARDIOGRAPHIC VISUAL VERSUS COMPUTERIZED EVALUATION OF THE DEGREE OF AORTIC VALVE CALCIFICATION IN PATIENTS WITH AORTIC VALVE AND ROOT PATHOLOGY (2010) (0)
FUNCTIONAL ANALYSIS OF THE BCAR1-CFDP1-TMEM170A LOCUS ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS AND PLAQUE (2014) (0)
Common polymorphisms in the factor VII gene locus influence the basal and postprandial plasma concentrations of activated factor VII (1999) (0)
GeneticLociAssociatedWithC-ReactiveProtein Levels and Risk of Coronary Heart Disease (2017) (0)
Myocardial lnfarction and Healthy Controls from Sweden (2018) (0)
Transient Defects in the Infarcted and Remote Myocardium, as Assessed by Thallium-201 Scintigraphy in Young Men after Myocardial Infarction (1992) (0)
2.P.348 Alpha fibronogen genotype is associated with the porosity and density of the fibrin gel matrix in MI patients (1997) (0)
An affinity proteomics study for plasma biomarker candidates of cardiovascular disease in venous thromboembolism (2015) (0)
Edinburgh Research Explorer Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes (2018) (0)
USE OF PCR TO GENOTYPE A POLYMORPHIC DINUCLEOTIDE REPEAT WITHIN THE PAI-1 GENE IN PATIENTS WITH A RECENT MI (1990) (0)
Reply to “Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population” (2008) (0)
In silico prediction of regulatory SNPs in the CD36 gene and evaluation of their effect in a clinical study for coronary artery disease (2007) (0)
Abstract 367: Pcsk6 Is a Key Protease Modulating Smooth Muscle Cell Activation in Vascular Remodeling and Plaque Vulnerability (2015) (0)
Functional Analysis of a Carotid Intima-Media Thickness Locus Implicates BCAR 1 and Suggests a Causal Variant Running title : Boardman-Pretty ; Analysis of cIMT locus : BCAR 1 and causal variant (2015) (0)
GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes (2018) (0)
A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke (2019) (0)
Cellular processing of apolipoprotein B‐containing lipoproteins from young post‐infarction patients and healthy controls (1995) (0)
Abstract 467: PCSK6 Is Upregulated in Vascular Diseases Characterized by Inflammation and Smooth Muscle Cell Proliferation (2014) (0)
[Temporary pacemaker treatment in acute myocardial infarction]. (1981) (0)
27 Fatty acids increase plasminogen activator inhibitor-1 expression and secretion in endothelial cells (1997) (0)
Correlation and Stability of Heart Rate and Ventricular Ectopy Variability in Patients With Congestive Heart Failure (2001) (0)
University of Groningen Genome-wide analysis yields new loci associating with aortic valve stenosis (2018) (0)
YI-798 ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA INCREASES THE EXPRESSION OF THE HUMAN APOLIPOPROTEIN A-II GENE (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Anders Hamsten?

Anders Hamsten is affiliated with the following schools:

Anders Hamsten's Academic­Influence.com Rankings

Why Is Anders Hamsten Influential?

Anders Hamsten's Published Works

Published Works

What Schools Are Affiliated With Anders Hamsten?

Anders Hamsten's AcademicInfluence.com Rankings